|
|
|
|
|
Robert J. Hayashi, M.D.
|
|
Associate Professor of Pediatrics
Director, Division of Hematology/Oncology
Hematology and Oncology
Patient Oriented Research
Dr. Hayashi is Director of the Division of Pediatric Hematology/Oncology and an attending physician in Hematology/Oncology and General Pediatrics at St. Louis Children’s Hospital. Dr. Hayashi's research interest primarily focuses on issues regarding the long term effects of cancer therapy. His efforts examine the nature and spectrum of clinical conditions that effect childhood cancer survivors with the goal of developing interventions that will improve the outlook of this patient population. He is involved in both institutional and national efforts to gain insight in this rapidly evolving area of investigation and he also directs The Late Effects Clinic at St. Louis Children’s Hospital providing comprehensive care for patients afflicted with a broad scope of conditions.
Dr. Hayashi's clinical interests also include bone marrow transplantation, Non-Hodgkin's Lymphoma and post-transplant lymphoproliferative disease (PTLD). He is actively involved in national trials advancing the treatment of patients in these areas.
|
Robert J. Hayashi, M.D.
|
|
Associate Professor of Pediatrics
Director, Division of Hematology/Oncology
Hematology and Oncology
Patient Oriented Research
Dr. Hayashi is Director of the Division of Pediatric Hematology/Oncology and an attending physician in Hematology/Oncology and General Pediatrics at St. Louis Children’s Hospital. Dr. Hayashi's research interest primarily focuses on issues regarding the long term effects of cancer therapy. His efforts examine the nature and spectrum of clinical conditions that effect childhood cancer survivors with the goal of developing interventions that will improve the outlook of this patient population. He is involved in both institutional and national efforts to gain insight in this rapidly evolving area of investigation and he also directs The Late Effects Clinic at St. Louis Children’s Hospital providing comprehensive care for patients afflicted with a broad scope of conditions.
Dr. Hayashi's clinical interests also include bone marrow transplantation, Non-Hodgkin's Lymphoma and post-transplant lymphoproliferative disease (PTLD). He is actively involved in national trials advancing the treatment of patients in these areas.
|
|
|
|
|
|
|
- B.S., Stanford University, 1982
- M.D., Washington University, 1986
- B.S., Stanford University, 1982
- M.D., Washington University, 1986
|
|
|
|
|
|
- Resident in Pediatrics, St. Louis Children's Hospital, 1987-1989
- Fellow in Pediatric Hematology/Oncology, The Johns Hopkins School of Medicine, 1989-1992
- Resident in Pediatrics, St. Louis Children's Hospital, 1987-1989
- Fellow in Pediatric Hematology/Oncology, The Johns Hopkins School of Medicine, 1989-1992
|
|
|
|
|
|
- Missouri License, 1994
- American Board of Pediatrics, 1990
- Pediatric Hematology and Oncology, 1992
- Missouri License, 1994
- American Board of Pediatrics, 1990
- Pediatric Hematology and Oncology, 1992
|
|
|
|
|
|
- Child Health Research Center Award, 1992
- National Institutes of Health, Physician Scientist Award, 1992-1997
- Legacy Award, National Children's Cancer Society, 2006
- Child Health Research Center Award, 1992
- National Institutes of Health, Physician Scientist Award, 1992-1997
- Legacy Award, National Children's Cancer Society, 2006
|
|
|
|
|
|
-
Hayashi RJ, Kraus MD, Lahoti A, Canter C, Cohen AH, Hmiel P, Howard T, Huddleston C, Lowell JA, Mallory G, Mendeloff E, Molleston J, Swet S, DeBaun MR, Post Transplant Lymphoproliferative Disease in children: Correlation of histology to clinical behavior. Journal of Pediatric Hematology/Oncology 2001 23 (1): 14-18.
-
Kadan-Lottic,N.S., Robison, L.L., Gurney, J.G., Neglia, J.P., Yasuii, Y., Hayashi, R., Hudson, M., Greenberg, M., Mertens, A.C., What Do Childhood Cancer Survivors Know About Their Past Diagnosis and Treatment?: The Childhood Cancer Survivor Study. JAMA 2002 287: 1832-1839.
-
Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ, Mohanakumar T,Rao A and Hayashi RJ: A novel reduced-intensity stem cell transplant regimen for nonmalignantdisorders. Bone Marrow Transplantation 35: 345-352, 2005.
-
Bluhm, E, Ronckers, C, Meadows, A, Mertens, AC, Robison, LL, Donaldson, S, Meacham, L, Hayashi, RJ, Sklar, CA, Kersun, LS, Whitton, J, Inskip, P.,Chronic Health Conditions and Function After Non-Hodgkin’s Lymphoma in the Childhood Cancer Survivor Study: Blood. 111(8):4014-21, 2008.
-
Hayashi RJ, Kraus MD, Lahoti A, Canter C, Cohen AH, Hmiel P, Howard T, Huddleston C, Lowell JA, Mallory G, Mendeloff E, Molleston J, Swet S, DeBaun MR, Post Transplant Lymphoproliferative Disease in children: Correlation of histology to clinical behavior. Journal of Pediatric Hematology/Oncology 2001 23 (1): 14-18.
-
Kadan-Lottic,N.S., Robison, L.L., Gurney, J.G., Neglia, J.P., Yasuii, Y., Hayashi, R., Hudson, M., Greenberg, M., Mertens, A.C., What Do Childhood Cancer Survivors Know About Their Past Diagnosis and Treatment?: The Childhood Cancer Survivor Study. JAMA 2002 287: 1832-1839.
-
Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ, Mohanakumar T,Rao A and Hayashi RJ: A novel reduced-intensity stem cell transplant regimen for nonmalignantdisorders. Bone Marrow Transplantation 35: 345-352, 2005.
-
Bluhm, E, Ronckers, C, Meadows, A, Mertens, AC, Robison, LL, Donaldson, S, Meacham, L, Hayashi, RJ, Sklar, CA, Kersun, LS, Whitton, J, Inskip, P.,Chronic Health Conditions and Function After Non-Hodgkin’s Lymphoma in the Childhood Cancer Survivor Study: Blood. 111(8):4014-21, 2008.
|
|
|